Lucid Diligence Brief: Greywolf Therapeutics and Genomics strategic partnership
Lucid Diligence Brief: Greywolf Therapeutics and Genomics strategic……
Lucid Diligence Brief: Huahui Health x BeOne Medicines $2 billion collaboration for cancer trispecific HH160
Lucid Diligence Brief: Huahui Health x BeOne Medicines $2 billion collaboration…
Lucid Diligence Brief: Teva to acquire Emalex Biosciences
Lucid Diligence Brief: Teva to acquire Emalex Biosciences Professional…
Lucid Diligence Brief: Profluent-Lilly AI-Designed Recombinase Partnership
Lucid Diligence Brief: Profluent-Lilly AI-Designed Recombinase Partnership…
Lucid Diligence Brief: Lilly to acquire Ajax Therapeutics
Lucid Diligence Brief: Lilly to acquire Ajax Therapeutics Professional…
AI in Healthcare and Digital Health Today—April 28, 2026
This week’s Artificial Intelligence and Digital Health update highlights…
Lucid Diligence Brief: Cantargia nadunolimab in MDS and AML
Lucid Diligence Brief: Cantargia nadunolimab in MDS and AML Professional…
Lucid Diligence Brief: Sun Pharma acquisition of Organon
Lucid Diligence Brief: Sun Pharma acquisition of Organon Professional audiences…
Lucid Diligence Brief: Regeneron Otarmeni FDA approval
Lucid Diligence Brief: Regeneron Otarmeni FDA approval Professional audiences…
Lucid Diligence Brief: Avalyn Pharma IPO
Lucid Diligence Brief: Avalyn Pharma IPO Professional audiences only. Not…
Lucid Diligence Brief: Viz.ai and Johnson & Johnson collaboration on AI-powered subdural hemorrhage care
Lucid Diligence Brief: Viz.ai and Johnson & Johnson collaboration on…
Lucid Diligence Brief: Merck × Google Cloud agentic AI partnership
Lucid Diligence Brief: Merck × Google Cloud agentic AI partnership Professional…